9,927 results
Search Results
152. Simple workflow to repurpose SARS-CoV-2 swab/serum samples for the isolation of cost-effective antibody/antigens for proteotyping applications and diagnosis.
- Author
-
Tok, Kerem, Moulahoum, Hichem, Ghorbanizamani, Faezeh, Harmanci, Duygu, Balaban Hanoglu, Simge, Durmus, Ceren, Evran, Serap, Cicek, Candan, Sertoz, Ruchan, Arda, Bilgin, Goksel, Tuncay, Turhan, Kutsal, Timur, Suna, and Zihnioglu, Figen
- Subjects
IMMUNOGLOBULINS ,SARS-CoV-2 ,DIAGNOSIS ,ANTIGENS ,BLOOD group antigens ,COVID-19 pandemic ,ISOTHERMAL titration calorimetry - Abstract
Supply shortage for the development and production of preventive, therapeutic, and diagnosis tools during the COVID-19 pandemic is an important issue affecting the wealthy and poor nations alike. Antibodies and antigens are especially needed for the production of immunological-based testing tools such as point-of-care tests. Here, we propose a simple and quick magnetic nanoparticle (MNP)–based separation/isolation approach for the repurposing of infected human samples to produce specific antibodies and antigen cocktails. Initially, an antibody cocktail was purified from serums via precipitation and immunoaffinity chromatography. Purified antibodies were conjugated onto MNPs and used as an affinity matrix to separate antigens. The characterization process was performed by ELISA, SDS-PAGE, electrochemistry, isothermal titration calorimetry, and LC-Q-TOF-MS/MS analyses. The MNP-separated peptides can be used for mass spectrometry–based as well as paper-based lateral flow assay diagnostic. The exploitation of the current workflow for the development of efficient diagnostic tools, specific treatments, and fundamental research can significantly impact the present or eventual pandemic. This workflow can be considered as a two birds, one stone–like strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
153. Point-of-care diagnosis of COVID-19 disease based on antigen tests.
- Author
-
M., Pohanka
- Subjects
COVID-19 ,SARS-CoV-2 ,ANTIGENS ,MEDICAL literature ,PRAXIS (Process) - Abstract
AIMS: This review is focused on the laboratory diagnoses of the coronavirus disease 2019 (COVID-19) by recognizing the antigen of the causative agent SARS-CoV-2 virus. Various antigen tests are available in this moment and these tests are being further developed in order to reach a better diagnostic value. The issue is reviewed in a complex view. METHODS: In this work, a complex survey of the current literature was made. The relevant and recent papers related to antigen tests of COVID-19 are discussed and cited. Basic specifications of the antigen tests and competitive methods were also scrutinized in the current literature. RESULTS: The survey of the current literature (years 2019 - 2021) was made and diagnostic methods like lateral flow tests (lateral flow immunochromatographic assay) and various types of biosensors were specified as tools for COVID-19 diagnosis and their application to be used as a point-of-care test is considered. CONCLUSIONS: Small hand-held assays applicable in the point-of-care conditions for diagnosis of COVID-19 by analysis of SARS-CoV-2 antigen are the means of a growing interest and these means undergo a significant development leading to the improvements of their specifications and applicability to the current praxis. Merit of the assays is discussed in this paper. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
154. Electronic and electrochemical viral detection for point-of-care use: A systematic review.
- Author
-
Monteil, Solen, Casson, Alexander J., and Jones, Samuel T.
- Subjects
FIELD-effect transistors ,POINT-of-care testing ,ELECTROCHEMICAL sensors ,IMPEDANCE spectroscopy ,DETECTION limit ,ANTIGENS ,VIRUS diseases - Abstract
Detecting viruses, which have significant impact on health and the economy, is essential for controlling and combating viral infections. In recent years there has been a focus towards simpler and faster detection methods, specifically through the use of electronic-based detection at the point-of-care. Point-of-care sensors play a particularly important role in the detection of viruses. Tests can be performed in the field or in resource limited regions in a simple manner and short time frame, allowing for rapid treatment. Electronic based detection allows for speed and quantitative detection not otherwise possible at the point-of-care. Such approaches are largely based upon voltammetry, electrochemical impedance spectroscopy, field effect transistors, and similar electrical techniques. Here, we systematically review electronic and electrochemical point-of-care sensors for the detection of human viral pathogens. Using the reported limits of detection and assay times we compare approaches both by detection method and by the target analyte of interest. Compared to recent scoping and narrative reviews, this systematic review which follows established best practice for evidence synthesis adds substantial new evidence on 1) performance and 2) limitations, needed for sensor uptake in the clinical arena. 104 relevant studies were identified by conducting a search of current literature using 7 databases, only including original research articles detecting human viruses and reporting a limit of detection. Detection units were converted to nanomolars where possible in order to compare performance across devices. This approach allows us to identify field effect transistors as having the fastest median response time, and as being the most sensitive, some achieving single-molecule detection. In general, we found that antigens are the quickest targets to detect. We also observe however, that reports are highly variable in their chosen metrics of interest. We suggest that this lack of systematisation across studies may be a major bottleneck in sensor development and translation. Where appropriate, we use the findings of the systematic review to give recommendations for best reporting practice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
155. Accurate Prediction and Key Feature Recognition of Immunoglobulin.
- Author
-
Gong, Yuxin, Liao, Bo, Peng, Dejun, and Zou, Quan
- Subjects
BLOOD proteins ,IMMUNOGLOBULINS ,B cells ,ANTIGENS ,IMMUNOGLOBULIN G - Abstract
Immunoglobulin, which is also called an antibody, is a type of serum protein produced by B cells that can specifically bind to the corresponding antigen. Immunoglobulin is closely related to many diseases and plays a key role in medical and biological circles. Therefore, the use of effective methods to improve the accuracy of immunoglobulin classification is of great significance for disease research. In this paper, the CC–PSSM and monoTriKGap methods were selected to extract the immunoglobulin features, MRMD1.0 and MRMD2.0 were used to reduce the feature dimension, and the effect of discriminating the two–dimensional key features identified by the single dimension reduction method from the mixed two–dimensional key features was used to distinguish the immunoglobulins. The data results indicated that monoTrikGap (k = 1) can accurately predict 99.5614% of immunoglobulins under 5-fold cross–validation. In addition, CC–PSSM is the best method for identifying mixed two–dimensional key features and can distinguish 92.1053% of immunoglobulins. The above proves that the method used in this paper is reliable for predicting immunoglobulin and identifying key features. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
156. Gene Targets of CAR-T Cell Therapy for Glioblastoma.
- Author
-
Wang, Chaoqun, Li, Yuntao, Gu, Lijuan, Chen, Ran, Zhu, Hua, Zhang, Xu, Zhang, Yonggang, Feng, Shi, Qiu, Sheng, Jian, Zhihong, and Xiong, Xiaoxing
- Subjects
CELLULAR therapy ,GLIOMAS ,CELL receptors ,BRAIN tumors ,GENETIC markers ,HEMATOLOGIC malignancies ,T cells ,IMMUNOTHERAPY ,ANTIGENS - Abstract
Simple Summary: Glioblastoma is the most prevalent cerebral cancer in adults without proven therapy. Chimeric antigen receptor T cell treatment has demonstrated good clinical success in hematologic cancers. The application of chimeric antigen receptor T cell therapy to solid tumors, such as glioblastoma, is currently the subject of scientific investigation. The creation of chimeric antigen receptor T cells and its iterations are briefly described in this article. Specifically, this study addresses the obstacles and hurdles faced and glioblastoma targets studied in recent years. This review provides the reader with a comprehensive understanding of the current state of chimeric antigen receptor T cell therapy for glioblastoma and a clear understanding of each therapeutic target. Glioblastoma (GBM) is an aggressive primary brain tumor with a poor prognosis following conventional therapeutic interventions. Moreover, the blood–brain barrier (BBB) severely impedes the permeation of chemotherapy drugs, thereby reducing their efficacy. Consequently, it is essential to develop novel GBM treatment methods. A novel kind of pericyte immunotherapy known as chimeric antigen receptor T (CAR-T) cell treatment uses CAR-T cells to target and destroy tumor cells without the aid of the antigen with great specificity and in a manner that is not major histocompatibility complex (MHC)-restricted. It has emerged as one of the most promising therapy techniques with positive clinical outcomes in hematological cancers, particularly leukemia. Due to its efficacy in hematologic cancers, CAR-T cell therapy could potentially treat solid tumors, including GBM. On the other hand, CAR-T cell treatment has not been as therapeutically effective in treating GBM as it has in treating other hematologic malignancies. CAR-T cell treatments for GBM have several challenges. This paper reviewed the use of CAR-T cell therapy in hematologic tumors and the selection of targets, difficulties, and challenges in GBM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
157. Patterned Biolayers of Protein Antigens for Label-Free Biosensing in Cow Milk Allergy.
- Author
-
Juste-Dolz, Augusto, Fernández, Estrella, Puchades, Rosa, Avella-Oliver, Miquel, and Maquieira, Ángel
- Subjects
MILK allergy ,LACTOGLOBULINS ,PROTEINS ,CASEINS ,ANTIGENS ,OPTICAL transducers ,PROTEIN structure - Abstract
This paper focuses on creating one-dimensional diffractive grooved structures of antigen proteins on glass substrates for the label-free detection of antibodies to dairy allergens. In particular, the fabrication of protein structures is carried out by combining microcontact printing with physisorption, imines coupling, and thiol-ene click chemistry. The work first sets up these patterning methods and discusses and compares the main aspects involved in them (structure, biolayer thickness, functionality, stability). Homogeneous periodic submicron structures of proteins are created and characterized by diffractive measurements, AFM, FESEM, and fluorescence scanning. Then, this patterning method is applied to proteins involved in cow milk allergy, and the resulting structures are implemented as optical transducers to sense specific immunoglobulins G. In particular, gratings of bovine serum albumin, casein, and β-lactoglobulin are created and assessed, reaching limits of detection in the range of 30–45 ng·mL
−1 of unlabeled antibodies by diffractive biosensing. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
158. Immunoproteomic analysis of fish ectoparasite, Argulus siamensis antigens.
- Author
-
Das, Priyanka, Badhe, Mohan R., Sahoo, Pramoda Kumar, Reddy, Raudu Rajendra Kumar, Suryawanshi, Amol R., and Mohanty, Jyotirmaya
- Subjects
ROHU ,IMMUNE serums ,ANTIGENS ,ACRYLAMIDE ,MASS spectrometry ,PROTEOMICS - Abstract
Aim: An immunoproteomic approach was followed to identify immunoreactive antigens of fish ectoparasite, Argulus siamensis with rohu (Labeo rohita) immune sera for screening of potential vaccine candidates. Materials and results: The whole adult Argulus antigen was run in 2D electrophoresis with IEF in 7 cm IPG strips of pH 4‐7 and SDS‐PAGE with 12% acrylamide concentration. Two parallel gels were run; one was stained with silver stain, and the other was Western blotted to nitrocellulose paper (NCP) and reacted with rohu anti‐A siamensis sera. Fourteen protein spots corresponding to the spots developed in NCP were picked from the silver‐stained gel and subjected to mass spectrometry in MALDI‐TOF/TOF. The MS/MS spectra were analysed in MASCOT software with taxonomy 'other metazoa' and the proteins identified based on similarity with the proteins from heterologous species. The gene ontology analysis revealed a majority of proteins being involved in binding activity in 'molecular function' and belonging to metabolic processes in 'biologic process' categories. The possibility of these proteins as vaccine candidates against Asiamensis is discussed in the paper. Conclusion: Three of the identified proteins namely, bromodomain‐containing protein, anaphase‐promoting complex subunit 5 and elongation factor‐2 could possibly serve as vaccine candidates against argulosis in carps. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
159. Are preoperative serum cancer antigen 125 levels a prognostic factor for outcome in epithelial ovarian cancer? A systematic review.
- Author
-
Muhammad, Shittu Adamu, Olaoye, Stephen Oyewole, and Umar, Farouk Kabir
- Subjects
CA 125 test ,OVARIAN epithelial cancer ,PROGNOSIS ,CINAHL database ,OVERALL survival ,NEOADJUVANT chemotherapy ,ANTIGENS - Abstract
Background: Most patients with epithelial ovarian cancers (EOC) present with advanced-stage disease because of non-specific symptoms and lack of reliable strategies for early diagnosis. Cancer antigen 125 (CA-125) is suggested as a useful prognostic biomarker, its serum level is raised in over 80.0% of patients with EOC. Primary debulking surgery (PDS) followed by chemotherapy is the conventional treatment, but neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) is offered to patients with unresectable disease. There are inconsistencies regarding the role of preoperative CA-125 serum levels to adopt in stratifying patients for treatment choice that offers the most benefit. This review aimed to determine the role of preoperative CA-125 levels in predicting optimal cytoreduction and the association between optimal cytoreduction and survival outcome in patients with EOC. Methodology: Three electronic databases CINAHL, Cochrane library and PubMed were searched for potentially relevant articles from 2016 to 2021 on the role of preoperative CA-125 levels in predicting optimal cytoreduction and survival in patients with epithelial ovarian carcinomas. Conclusion: In patients who underwent NACT-IDS, a lower preoperative CA-125 value is a predictor of optimal cytoreduction and an increase in preoperative CA-125 value is consistently associated with a decrease in optimal cytoreduction. There was insufficient data to assess overall survival. However, a raised preoperative CA-125 level is poor predictor of chance of achieving optimal cytoreduction and the rate of optimal cytoreduction was a weak predictor of overall survival in women who had primary debulking surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
160. Universal scaling theory of electrochemical immunosensors: An analytical approach to define and compare performance metrics.
- Author
-
Fratus, Marco and Alam, Muhammad A.
- Subjects
DIFFUSION measurements ,DETECTION limit ,MODELS & modelmaking ,ANTIGENS ,BIOMOLECULES - Abstract
Electrochemical immunosensors have emerged as a versatile, sensitive, and selective sensor technology of choice for a variety of applications, including detection of proteins, food pathogens, bacteria, viruses, and cancerous molecules. The combination of highly specific biorecognition elements and electrical readout systems facilitates the detection of antigens down to femtomolar concentrations. However, a lack of quantitative theoretical framework has made the design, optimization, and comparison of sensors difficult, without a clear and definitive understanding of the limits of detection, dynamic range, and sensitivity. In this paper, we integrate reaction-diffusion and effective media theories to derive a generalized scaling model for an arbitrary immunosensor that relates the relative change of redox current to the corresponding change in antigen concentration, through scaling exponents related to the geometry of biomolecules diffusion and the measurement resolution. Experimental data from dozens of immunosensors (for a variety of antigens, material systems, and sensor geometry) validate our sensor-agnostic scaling formula. Our results would allow cross-calibration of the emerging and traditional immunosensors reported across the literature and define a physics-based, standardized methodology to compare performance metrics, such as limits of detection, dynamic range, and sensitivity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
161. A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated with a Recombinant Cytomegalovirus (CMV) Pentamer Antigen in Mice.
- Author
-
Lodaya, Rushit N., Kanitkar, Amey P., Ashraf, Asma, Bamba, Douty, Amiji, Mansoor M., and O'Hagan, Derek T.
- Subjects
ANTIBODY formation ,EMULSIONS ,COMBINED vaccines ,ANTIGENS ,INFLUENZA vaccines - Abstract
The development of new vaccine adjuvants represents a key approach to improvingi the immune responses to recombinant vaccine antigens. Emulsion adjuvants, such as AS03 and MF59, in combination with influenza vaccines, have allowed antigen dose sparing, greater breadth of responses and fewer immunizations. It has been demonstrated previously that emulsion adjuvants can be prepared using a simple, low-shear process of self-emulsification (SE). The role of alpha tocopherol as an immune potentiator in emulsion adjuvants is clear from the success of AS03 in pandemic responses, both to influenza and COVID-19. Although it was a significant formulation challenge to include alpha tocopherol in an emulsion prepared by a low-shear process, the resultant self-emulsifying adjuvant system (SE-AS) showed a comparable effect to the established AS03 when used with a quadrivalent influenza vaccine (QIV). In this paper, we first optimized the SE-AS with alpha tocopherol to create SE-AS44, which allowed the emulsion to be sterile-filtered. Then, we compared the in vitro cell activation cytokine profile of SE-AS44 with the self-emulsifying adjuvant 160 (SEA160), a squalene-only adjuvant. In addition, we evaluated SE-AS44 and SEA160 competitively, in combination with a recombinant cytomegalovirus (CMV) pentamer antigen mouse. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
162. Maturation of Aluminium Adsorbed Antigens Contributes to the Creation of Homogeneous Vaccine Formulations.
- Author
-
Laera, Donatello, Scarpellini, Camilla, Tavarini, Simona, Baudner, Barbara, Marcelli, Agnese, Pergola, Carlo, Meppen, Malte, and O'Hagan, Derek T.
- Subjects
ANTIGENS ,ALUMINUM ,VACCINES ,ALUMINUM hydroxide - Abstract
Although aluminium-based vaccines have been used for almost over a century, their mechanism of action remains unclear. It is established that antigen adsorption to the adjuvant facilitates delivery of the antigen to immune cells at the injection site. To further increase our understanding of aluminium-based vaccines, it is important to gain additional insights on the interactions between the aluminium and antigens, including antigen distribution over the adjuvant particles. Immuno-assays can further help in this regard. In this paper, we evaluated how established formulation strategies (i.e., sequential, competitive, and separate antigen addition) applied to four different antigens and aluminium oxyhydroxide, lead to formulation changes over time. Results showed that all formulation samples were stable, and that no significant changes were observed in terms of physical-chemical properties. Antigen distribution across the bulk aluminium population, however, did show a maturation effect, with some initial dependence on the formulation approach and the antigen adsorption strength. Sequential and competitive approaches displayed similar results in terms of the homogeneity of antigen distribution across aluminium particles, while separately adsorbed antigens were initially more highly poly-dispersed. Nevertheless, the formulation sample prepared via separate adsorption also reached homogeneity according to each antigen adsorption strength. This study indicated that antigen distribution across aluminium particles is a dynamic feature that evolves over time, which is initially influenced by the formulation approach and the specific adsorption strength, but ultimately leads to homogeneous formulations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
163. Terahertz Combined with Metamaterial Microfluidic Chip for Troponin Antigen Detection.
- Author
-
Lin, Yen-Shuo, Huang, Shih-Ting, Hsu, Shen-Fu, Tang, Kai-Yuan, Yen, Ta-Jen, and Yao, Da-Jeng
- Subjects
TROPONIN ,METAMATERIALS ,ANTIGENS ,IMMUNOGLOBULINS ,FLUORESCENT antibody technique ,MICROFLUIDICS - Abstract
In this paper, we use terahertz combined with metamaterial technology as a powerful tool to identify analytes at different concentrations. Combined with the microfluidic chip, the experimental measurement can be performed with a small amount of analyte. In detecting the troponin antigen, surface modification is carried out by biochemical binding. Through the observation of fluorescent antibodies, the average number of fluorescent dots per unit of cruciform metamaterial is 25.60, and then, by adjusting the binding temperature and soaking time, the average number of fluorescent dots per unit of cruciform metamaterial can be increased to 181.02. Through the observation of fluorescent antibodies, it is confirmed that the antibodies can be successfully stabilized on the metamaterial and then bound to the target antigen. The minimum detectable concentration is between 0.05~0.1 μg/100 μL, and the concentration and ΔY show a positive correlation of R
2 = 0.9909. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
164. Fc Gamma Receptor IIIB NA1/NA2/SH Polymorphisms Are Associated with Malaria Susceptibility and Antibody Levels to P. falciparum Merozoite Antigens in Beninese Children.
- Author
-
Fall, Abdou Khadre Dit Jadir, Courtin, David, Adamou, Rafiou, Edslev, Sofie, Hansen, Anita, Domingo, Nadia, Christiansen, Michael, Adu, Bright, Milet, Jacqueline, Garcia, André, Theisen, Michael, Migot-Nabias, Florence, and Dechavanne, Célia
- Subjects
FC receptors ,MALARIA ,ANTIGENS ,ANTIBODY formation ,HAPLOTYPES ,IMMUNOGLOBULINS ,GABA receptors - Abstract
This paper aimed to investigate the influence of polymorphisms in the FCGR2A gene encoding R131H FcgRIIA variants and in the FCGR3B gene (108G > C, 114C > T, 194 A > G, 233C > A, 244 G > A and 316G > A) encoding FcgRIIIB-NA1, -NA2 and -SH variants on malaria susceptibility and antibody responses against P. falciparum merozoite antigens in Beninese children. An active malaria follow-up was conducted in infants from birth to 24 months of age in Allada, Benin. FCGR3B exon 3 was sequenced and FCGR2A exon 4 was genotyped. Antibodies directed to GLURP and MSP3 were quantified by ELISA. Association studies were performed using mixed-effect models. Individual carriage of FCGR3B 194 AA genotype was associated with a high number of malaria infections and a low level of IgG1 against MSP3 and GLURP-R0. High parasitemia and increased malaria infections were observed in infants carrying the FCGR3B*05 108C-114T-194A-233C-244A-316A haplotype. A reduced risk of malaria infections and low parasitemia were related to the carriages of the FCGR3B 108C-114T-194G-233C-244G-316A (FCGR3B*06), FCGR3B 108C–114T–194G–233A–244A–316A (FCGR3B*03 encoding for FcgRIIIB-SH) haplotypes and FCGR3B 297 TT genotype. Our results highlight the impact of FCGR3B polymorphisms on the individual susceptibility to malaria and antibody responses against MSP3 and GLURP in Beninese children. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
165. Identification and prioritization of tumour-associated antigens for immunotherapeutic and diagnostic capacity in epithelial ovarian cancer: a systematic literature review.
- Author
-
Wiseman, Lucy, Cinti, Noemi, and Guinn, Barbara-ann
- Subjects
SCIENTIFIC literature ,OVARIAN epithelial cancer ,ANTIGENS ,LITERARY sources - Abstract
Epithelial ovarian cancer (EOC) is a prevalent carcinoma in the female population associated with poor prognostic outcomes, in part due to the late stage of the disease at diagnosis. Aiming to identify tumour-associated antigens (TAAs) with the potential to facilitate earlier detection and targeted therapy of EOC, five scientific literature repositories were systemically searched for primary literature sources reporting the expression of a TAA in the tissue or serum of adult females diagnosed with EOC and healthy women. We identified 7120 articles of which 32 met our inclusion criteria and passed the bias-quality assessment. Subsequently, data were collated on 29 TAAs whose expression had been analysed in 2181 patients and 589 healthy individuals. Reports of CA125 and EpCAM expression were numerous while tissue expression data were available for 28 TAAs. Data were segregated into three meta-cohorts for statistical scrutiny and their capacity for diagnostic and treatment targeting was assessed. We showed that CA-125 was expressed homogenously in EOC patients while EpCAM was expressed heterogeneously. CA-125 was the most promising TAA target for both diagnosis and treatment, gaining a priority score of 12 (/12) while EpCAM gained a priority score of seven. Tissue expression of EOC TAAs was homogenous; 90% of the EOC population express any identified TAA while just 20% of healthy individuals will be positive for the same TAA. We suggest TAA profiling should be a fundamental aspect of EOC diagnosis, sitting alongside the FIGO framework, promoting reduced mortality and directing the development of TAA-targeted therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
166. A fully integrated paperfluidic molecular diagnostic chip for the extraction, amplification, and detection of nucleic acids from clinical samples.
- Author
-
Rodriguez, Natalia M., Wong, Winnie S., Liu, Lena, Dewar, Rajan, and Klapperich, Catherine M.
- Subjects
MOLECULAR diagnosis ,INTEGRATED circuits ,EXTRACTION (Chemistry) ,WAVE amplification ,NUCLEIC acids ,ANTIGENS ,IMMUNOASSAY - Abstract
Paper diagnostics have successfully been employed to detect the presence of antigens or small molecules in clinical samples through immunoassays; however, the detection of many disease targets relies on the much higher sensitivity and specificity achieved via nucleic acid amplification tests (NAAT). The steps involved in NAAT have recently begun to be explored in paper matrices, and our group, among others, has reported on paper-based extraction, amplification, and detection of DNA and RNA targets. Here, we integrate these paper-based NAAT steps into a single paperfluidic chip in a modular, foldable system that allows for fully integrated fluidic handling from sample to result. We showcase the functionality of the chip by combining nucleic acid isolation, isothermal amplification, and lateral flow detection of human papillomavirus (HPV) 16 DNA directly from crude cervical specimens in less than 1 hour for rapid, early detection of cervical cancer. The chip is made entirely of paper and adhesive sheets, making it low-cost, portable, and disposable, and offering the potential for a point-of-care molecular diagnostic platform even in remote and resource-limited settings. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
167. Breast cancer detection based on cancer antigen 15-3; emphasis on optical and electrochemical methods: A review.
- Author
-
Pourmadadi, Mehrab, Ghaemi, Amirhossein, Khanizadeh, Amirhossein, Yazdian, Fatemeh, Mollajavadi, Yasin, Arshad, Rabia, and Rahdar, Abbas
- Subjects
- *
EARLY detection of cancer , *BREAST cancer , *TUMOR markers , *CANCER diagnosis , *ANTIGENS , *POINT-of-care testing - Abstract
Cancer antigen 15–3 (CA 15-3) is a crucial marker used in the diagnosis and monitoring of breast cancer (BC). The demand for early and precise cancer detection has grown, making the creation of biosensors that are highly sensitive and specific essential. This review paper provides a thorough examination of the progress made in optical and electrochemical biosensors for detecting the cancer biomarker CA 15-3. We focus on explaining their fundamental principles, sensitivity, specificity, and potential for point-of-care applications. The performance attributes of these biosensors are assessed by considering their limits of detection, reaction times, and operational stability, while also making comparisons to conventional methods of CA 15-3 detection. In addition, we explore the incorporation of nanomaterials and innovative transducer components to improve the performance of biosensors. This paper conducts a thorough examination of recent studies to identify the existing obstacles. It also suggests potential areas for future research in this fast progressing field.The paper provides insights into their advancement and utilization to enhance patient outcomes. Both categories of biosensors provide significant promise for the detection of CA 15-3 and offer distinct advantages compared to conventional analytical approaches. [Display omitted] • Identification of CA15-3 cancer biomarker can be done with aptamer-based biosensors • Further research needs to be carried out to use them in point-of-care diagnostics • Nanoaptasensors show very low detection limits and are used for in vivo detection • Their toxicity needs to be evaluated prior to their application in clinical diagnosis [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
168. Thyroid Antigens, Not Central Tolerance, Control Responses to Immunization in BALB/c Versus C57BL/6 Mice.
- Author
-
Alexander V. Misharin, Basil Rapoport, and Sandra M. McLachlan
- Subjects
THYROTROPIN ,ANTIGENS ,IMMUNIZATION ,LABORATORY mice - Abstract
Background:Vaccination with cDNA for the human thyrotropin receptor (TSHR) in a plasmid, without adjuvant, induces TSHR antibodies in C57BL/6 but rarely in BALB/c mice. This outcome could be due to a difference between “high” versus “low” antibody responder mouse strains. However, unlike their poor response to TSHR-DNA vaccination, BALB/c mice vaccinated with thyroid peroxidase (TPO)-cDNA readily develop antibodies to TPO. We hypothesized that insight into these conundrums would be provided by the following differences in central tolerance: (i) between two mouse strains (C57BL/6 versus BALB/c) for the TSHR; and (ii) between two thyroid autoantigens (TPO and the TSHR) in one mouse strain (BALB/c).Methods:We studied autoantigen expression using real-time polymerase chain reaction to quantify mRNA transcripts for the TSHR, TPO, and thyroglobulin (Tg) in thymic tissue (as well as in thyroid) of young mice.Results:Our hypothesis was not confirmed. Intrathymic TSHR transcript expression was similar in BALB/c and C57BL/6 mice. Moreover, thymic mRNA transcripts for TSHR and TPO were comparable. Unlike the 10-fold differences for the autoantigens in thyroid tissue (Tg greater than TPO which, in turn was greater than the TSHR), intrathymic transcripts for TPO and the TSHR were similar, both being slightly lower than the level for Tg.Conclusions:Central tolerance, assessed by measuring intrathymic transcripts of thyroid autoantigens, does not explain the different outcome of TSHR-DNA vaccination in BALB/c and C57BL/6 mice, or even susceptibility versus resistance to hyperthyroidism induced by TSHR-adenovirus. Instead, differences in MHC and TSHR T-cell epitopes likely contribute to TSHR antibody development (or not) following DNA plasmid immunization. The greater immunogenicity of TPO versus TSHR probably relates to the greater number of nonhomologous amino acids in the human and mouse TPO ectodomains (78 amino acids) than in the human and mouse TSHR ectodomains (58 amino acids). Overall, the autoantigens themselves, not central tolerance, control DNA plasmid–induced immunity to TPO and the TSHR. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
169. Haemonchosis in Sheep and Goats, Control Strategies and Development of Vaccines against Haemonchus contortus.
- Author
-
Adduci, Isabella, Sajovitz, Floriana, Hinney, Barbara, Lichtmannsperger, Katharina, Joachim, Anja, Wittek, Thomas, and Yan, Shi
- Subjects
HAEMONCHUS contortus ,VACCINE development ,ANIMAL welfare ,GOATS ,BIOLOGICAL fitness ,HELMINTHS - Abstract
Simple Summary: Haemonchus contortus is the most pathogenic blood-feeding parasitic nematode in sheep and goats, threatening animal welfare and causing tremendous economic losses to the small ruminant industry. This comprehensive review article sums up current control strategies, worm-derived antigens and recent advances in anti-Haemonchus vaccine development. New insights into antigen engineering and general considerations for clinical trials are discussed here. The evolutionary success of parasitic worms causes significant economic losses and animal health problems, including in the small ruminant industry. The hematophagous nematode Haemonchus contortus is a common endoparasite that infects wild and domestic ruminants worldwide, especially in tropical and subtropical regions. To date, the most commonly applied control strategy is the administration of anthelminthic drugs. The main disadvantages of these chemicals are their ecotoxic effects, the necessary withdrawal period (especially important in dairy animals) and the increasing development of resistance. Vaccines offer an attractive alternative control strategy against Haemonchus infections. In previous years, several potential vaccine antigens prepared from H. contortus using the latest technologies have been assessed in clinical trials using different methods and strategies. This review highlights the current state of knowledge on anti-H. contortus vaccines (covering native, recombinant and DNA-based vaccines), including an evaluation, as well a discussion of the challenges and achievements in developing protective, efficient, and long-lasting vaccines to control H. contortus infection and haemonchosis in small ruminants. This paper also addresses novel developments tackling the challenge of glycosylation of putative candidates in recombinant form. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
170. SEMA: Antigen B-cell conformational epitope prediction using deep transfer learning.
- Author
-
Shashkova, Tatiana I., Umerenkov, Dmitriy, Salnikov, Mikhail, Strashnov, Pavel V., Konstantinova, Alina V., Lebed, Ivan, Shcherbinin, Dmitriy N., Asatryan, Marina N., Kardymon, Olga L., and Ivanisenko, Nikita V.
- Subjects
DEEP learning ,ANTIGENS ,BINDING sites ,TERTIARY structure ,PROTEIN models ,CONFORMATIONAL analysis - Abstract
One of the primary tasks in vaccine design and development of immunotherapeutic drugs is to predict conformational B-cell epitopes corresponding to primary antibody binding sites within the antigen tertiary structure. To date, multiple approaches have been developed to address this issue. However, for a wide range of antigens their accuracy is limited. In this paper, we applied the transfer learning approach using pretrained deep learning models to develop a model that predicts conformational B-cell epitopes based on the primary antigen sequence and tertiary structure. A pretrained protein language model, ESM-1v, and an inverse folding model, ESM-IF1, were fine-tuned to quantitatively predict antibody-antigen interaction features and distinguish between epitope and non-epitope residues. The resulting model called SEMA demonstrated the best performance on an independent test set with ROC AUC of 0.76 compared to peer-reviewed tools. We show that SEMA can quantitatively rank the immunodominant regions within the SARS-CoV-2 RBD domain. SEMA is available at https://github.com/AIRI-Institute/SEMAi and the web-interface http://sema.airi.net. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
171. The Role of Yersinia pestis Antigens in Adhesion to J774 Macrophages: Optical Trapping Study.
- Author
-
Konyshev, I. V., Ivanov, S. A., Kopylov, P. H., Anisimov, A. P., Dentovskaya, S. V., and Byvalov, A. A.
- Subjects
YERSINIA pestis ,GARLIC ,CELL surface antigens ,ANTIGENS ,MACROPHAGES ,EUKARYOTIC cells - Abstract
The paper reports the assessment of the role of surface antigens in Yersinia pestis adhesion to murine macrophages J774. The ability of Ail and Psa antigens to adhere to eukaryotic cells has been confirmed using optical trapping and/or passive adhesion methods. The YapF autotransporter was shown for the first time to be an adhesin of Y. pestis. It has been suggested that these antigens do not have complementary receptors on the macrophage surface and their adhesive properties are nonspecific. The results of studying passive adhesion of polystyrene microspheres sensitized with the F1 capsular antigen to J774 macrophages suggest that its inhibiting effect on the adhesion to macrophages is determined not only by spatial shielding of underlying adhesins by the capsule but also by physical and chemical properties of the antigen itself. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
172. Precipitating Antibodies in Sheep Infested with Psoroptes ovis (Acarina: Psoroptidae), the Sheep Scab Mite
- Author
-
Fisher, William F.
- Published
- 1972
- Full Text
- View/download PDF
173. Antigens in Insulin Determinants of Specificity of Porcine Insulin in Man
- Author
-
Berson, Solomon A. and Yalow, Rosalyn S.
- Published
- 1963
174. Sharp Interfacial Precipitin Reactions in Capillary Pipettes
- Author
-
Swift, Homer F.
- Published
- 1947
175. Fluorescence Activation Spectra of a Diphosphopyridine Nucleotide Dependent Dehydrogenase
- Author
-
Winer, A. D. and Schwert, G. W.
- Published
- 1958
176. Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis.
- Author
-
Yoon, Edward J., Zhang, Jiahao, Weinberg, Rona S., Brochstein, Joel A., Nandi, Vijay, Sachais, Bruce S., and Shi, Patricia A.
- Subjects
STANDARD deviations ,T cells ,PROGENITOR cells ,LEUKAPHERESIS ,HEMATOPOIETIC stem cells ,ALGORITHMS ,ANTIGENS - Abstract
Background: Cellular therapies using engineered T cells, haploidentical transplants, and autologous gene therapy are increasing. Specified CD3+ or high CD34+ doses are typically required for subsequent manufacturing, manipulation, or CD34+ selection. Simple, practical, and reliable lymphocyte and hematopoietic progenitor cell (HPC) collection algorithms accounting for subsequent CD34+ selection have not been published.Study Design and Methods: In this analysis of 15 haploidentical donors undergoing tandem lymphocyte and HPC collections, we validated one-step, practical prediction algorithms (Appendix S1, available as supporting information in the online version of this paper) that use conservative facility-specific collection efficiencies, CD34+ selection efficiency, and donor-specific peripheral counts to reliably achieve the target CD3+ and CD34+ product doses. These algorithms expand on our previously published work regarding predictive HPC collection algorithms.Results: Ninety-three percent of lymphocyte and 93% of CD34+ collections achieved the final target CD3+ and CD34+ product dose when our algorithm-calculated process volumes were used. Linear regression analysis of our algorithms for CD3+, preselection CD34+, and postselection CD34+ showed statistically significant models with R2 of 0.80 (root mean square error [RMSE], 31.3), 0.72 (RMSE, 385.7), and 0.56 (RMSE, 326.0), respectively, all with p values less than 0.001.Conclusion: Because achievement of CD3+ or CD34+ dose targets may be critical for safety and efficacy of cell therapies, these simple, practical, and reliable prediction algorithms for lymphocyte and HPC collections should be very useful for collection facilities. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
177. A hybrid genetic-immune algorithm with improved lifespan and elite antigen for flow-shop scheduling problems.
- Author
-
Chang, Pei-Chann, Huang, Wei-Hsiu, and Ting, Ching-Jung
- Subjects
GENETIC algorithms ,SCHEDULING software ,PERMUTATIONS ,PRODUCTION control ,ANTIGENS ,LIFE spans - Abstract
In this paper, a hybrid genetic-immune algorithm (HGIA) is proposed to reduce the premature convergence problem in a genetic algorithm (GA) in solving permutation flow-shop scheduling problems. A co-evolutionary strategy is proposed for efficient combination of GA and an artificial immune system (AIS). First, the GA is adopted to generate antigens with better fitness, and then the population in the last generation is transformed into antibodies in AIS. A new formula for calculating the lifespan of each antibody is employed during the evolution processes. In addition, a new mechanism including T-cell and B-cell generation procedures is applied to produce different types of antibodies which will be merged together. The antibodies with longer lifespan will survive and enter the next generation. This co-evolutionary strategy is very effective since chromosomes and antibodies will be transformed and evolved dynamically. The intensive experimental results show the effectiveness of the HGIA approach. The hybrid algorithm can be further extended to solve different combinatorial problems. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
178. Interaction of Specific Monoclonal Antibodies with Leukocyte Antigens in Camels.
- Author
-
Alalai, Mohammed Ameer, Alkuwayti, Mayyadah Abdullah, Alrabiah, Noof Abdulrahman, and Hussen, Jamal
- Subjects
MONOCLONAL antibodies ,CAMELS ,LEUCOCYTES ,ANTIGENS ,BIOMARKERS - Abstract
The dromedary camel as a livestock species significantly impacts the economy of arid and semi-arid regions worldwide. The identification of cross-reactive antibodies against pivotal immune cell markers acts as a valuable method to investigate the immune system of camels. The aim of the present study was to identify new monoclonal antibodies that react with camel leukocyte subsets using flow cytometry and multicolor immunofluorescence. The expression patterns of the tested antibodies indicated cross-reactivity of the anti-bovine CD9 monoclonal antibody clones LT86A and Hl9a with different binding potential. Although all leukocyte subpopulations stained positively with the CD9 antibodies, monocytes showed the highest CD9 abundance, compared to lymphocytes and granulocytes. No cross-reactivity was identified for the tested monoclonal antibodies against equine CD8a (clone: ETC142BA1), mouse CD3 (clone: CD3-12), human CD3 (clone: T3/2/16A9), human CD206 (clone: MMR), and bovine granulocytes (clone: CH138A). The present study revealed that only camel monocytes showed positive staining with the anti-ovine CD5 mAb (clone ST1), which is in contrast to the human and murine systems. The present findings indicated low homogeneity between camels and other species in the antigenic structure of leukocyte antigens, highlighting the need to develop camel-specific mAbs against the main immune cell markers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
179. T-Cell Intracellular Antigen 1-Like Protein in Physiology and Pathology.
- Author
-
Velasco, Beatriz Ramos and Izquierdo, José M.
- Subjects
PHYSIOLOGY ,T cells ,RNA-binding proteins ,ANTIGENS ,CELL death ,NUCLEOCYTOPLASMIC interactions ,CYTOTOXIC T cells ,NUCLEAR membranes - Abstract
T-cell intracellular antigen 1 (TIA1)-related/like (TIAR/TIAL1) protein is a multifunctional RNA-binding protein (RBP) involved in regulating many aspects of gene expression, independently or in combination with its paralog TIA1. TIAR was first described in 1992 by Paul Anderson's lab in relation to the development of a cell death phenotype in immune system cells, as it possesses nucleolytic activity against cytotoxic lymphocyte target cells. Similar to TIA1, it is characterized by a subcellular nucleo-cytoplasmic localization and ubiquitous expression in the cells of different tissues of higher organisms. In this paper, we review the relevant structural and functional information available about TIAR from a triple perspective (molecular, cellular and pathophysiological), paying special attention to its expression and regulation in cellular events and processes linked to human pathophysiology. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
180. Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.
- Author
-
Szlasa, Wojciech, Janicka, Natalia, Sauer, Natalia, Michel, Olga, Nowak, Bernadetta, Saczko, Jolanta, and Kulbacka, Julita
- Subjects
CANCER cells ,MEMBRANE proteins ,ANTIGENS ,THERAPEUTICS ,DRUG therapy - Abstract
Cancer cells possess specific properties, such as multidrug resistance or unlimited proliferation potential, due to the presence of specific proteins on their cell membranes. The release of proliferation-related proteins from the membrane can evoke a loss of adaptive ability in cancer cells and thus enhance the effects of anticancer therapy. The upregulation of cancer-specific membrane antigens results in a better outcome of immunotherapy. Moreover, cytotoxic T-cells may also become more effective when stimulated ex-vivo toward the anticancer response. Therefore, the modulation of membrane proteins may serve as an interesting attempt in anticancer therapy. The presence of membrane antigens relies on various physical factors such as temperature, exposure to radiation, or drugs. Therefore, changing the tumor microenvironment conditions may lead to cancer cells becoming sensitized to subsequent therapy. This paper focuses on the therapeutic approaches modulating membrane antigens and enzymes in anticancer therapy. It aims to analyze the possible methods for modulating the antigens, such as pharmacological treatment, electric field treatment, photodynamic reaction, treatment with magnetic field or X-ray radiation. Besides, an overview of the effects of chemotherapy and immunotherapy on the immunophenotype of cancer cells is presented. Finally, the authors review the clinical trials that involved the modulation of cell immunophenotype in anticancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
181. COVID-BIOCHIP: A Web Tool to Analyse COVID-19 Antigen Microarrays.
- Author
-
SUCRE, Aurora, AMAYA-RODRIGUEZ, Isabel, RHO, Hee-Sool, SERNA, Sonia, REICHARDT, Niels, GARIN-MUGA, Alba, and EPELDE, Gorka
- Abstract
During the COVID-19 pandemic, there was a growing need to characterise the disease. A very important aspect is the ability to measure the immunisation extent, which can be achieved using antigen microarrays that quantitively measure the presence of COVID-related antibodies. A significant limitation for these tests was the complexity of manually analysing the results, and the limited availability of software for its analysis. In this paper, we describe the development of COVID-BIOCHIP, an ad-hoc web-based solution for the automatic analysis and visualisation of COVID-19 antigen microarray data results. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
182. Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.
- Author
-
Greene, Sarah E., Fischer, Kerstin, Choi, Young-Jun, Curtis, Kurt C., Budge, Philip J., Mitreva, Makedonka, King, Christopher L., Fischer, Peter U., and Weil, Gary J.
- Subjects
BURULI ulcer ,NEGLECTED diseases ,PARASITIC diseases ,SERODIAGNOSIS ,ANTIGENS ,ANTIBODY titer - Abstract
Background: Lymphatic filariasis (LF) is a neglected tropical disease caused by the filarial nematodes Wuchereria bancrofti, Brugia malayi and Brugia timori. The Global Program to Eliminate LF uses mass drug administration (MDA) of anti-filarial drugs that clear microfilariae (Mf) from blood to interrupt transmission by mosquitos. New diagnostic tools are needed to assess the impact of MDA on bancroftian filariasis, because available serologic tests can remain positive after successful treatment. Methodology/Principal findings: We identified Wb-bhp-1, which encodes a W. bancrofti homologue of BmR1, the B. malayi protein used in the Brugia Rapid antibody test for brugian filariasis. Wb-bhp-1 has a single exon that encodes a 16.3 kD protein (Wb-Bhp-1) with 45% amino acid identity to BmR1. Immunohistology shows that anti-Wb-Bhp-1 antibodies primarily bind to Mf. Plasma from 124 of 224 (55%) microfilaremic individuals had IgG4 antibodies to Wb-Bhp-1 by ELISA. Serologic reactivity to Wb-Bhp-1 varied widely with samples from different regions (sensitivity range 32–92%), with 77% sensitivity for 116 samples collected from microfilaremic individuals outside of sub-Saharan Africa. This variable sensitivity highlights the importance of validating new diagnostic tests for parasitic diseases with samples from different geographical regions. Individuals with higher Mf counts were more likely to have anti-Wb-Bhp-1 antibodies. Cross-reactivity was observed with a minority of plasma samples from people with onchocerciasis (17%) or loiasis (10%). We also identified, cloned and characterized BmR1 homologues from O. volvulus and L. loa that have 41% and 38% identity to BmR1, respectively. However, antibody assays with these antigens were not sensitive for onchocerciasis or loiasis. Conclusions: Wb-Bhp-1 is a novel antigen that is useful for serologic diagnosis of bancroftian filariasis. Additional studies are needed to assess the value of this antigen for monitoring the success of filariasis elimination programs. Author summary: Lymphatic filariasis (LF) is a highly disabling and stigmatizing disease caused by parasitic worms that are transmitted by mosquitoes. There is a coordinated global effort to eliminate LF based on mass drug administration (MDA) of donated anti-filarial medications. Improved methods are needed to determine when transmission of the infection has been interrupted in previously endemic areas so that MDA can be safely stopped. This paper reports the discovery and characterization of a novel W. bancrofti antigen, Wb-Bhp-1, which is a homologue of the Brugia malayi protein used in antibody tests to monitor filariasis elimination in areas of Asia where LF is caused by Brugia species. We show that a test for IgG4 antibodies to Wb-Bhp-1 was fairly specific for W. bancrofti infection. However, the sensitivity of this test varied by the geographic origin of the samples. Sensitivity was highest for samples collected in the Indo-Pacific region and lowest for samples collected in Côte d'Ivoire. Geographic differences in the parasite or the human immune responses to infection may account for this variability. This range in sensitivity highlights the importance of validating new diagnostic tests for parasitic diseases with samples from different geographical regions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
183. Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get".
- Author
-
Soleymaninejadian, Ehsan, Zelini, Paola, Cassaniti, Irene, Baldanti, Fausto, Dominoni, Mattia, Gritti, Andrea, and Gardella, Barbara
- Subjects
REGULATORY B cells ,VIRAL antigens ,TUMOR antigens ,KILLER cells ,HEAD & neck cancer ,HUMORAL immunity ,ANTIGENS - Abstract
The human papillomavirus (HPV) can cause different cancers in both men and women. The virus interferes with functions of the cervix, vulva, vagina, anus in the anogenital area, breast, and head and neck cancer due to the local lesions. The tumors lead to death if not treated as a result of distant metastasis to internal organs and brain. Moreover, HPV attenuates the immune system during chronic infection and releases viral antigens into the tumor microenvironment. The tumors know how difficult is to win the battle with a strong united army of immune cells that are equipped with cytokines and enzymes. They confuse the immune cells with secreting viral antigens. The immune system is equipped with cytokines, a complement system, antibodies, and other secretory proteins to overcome the foreign invaders and viral antigens. However, the majority of the time, tumors win the battle without having all the equipment of the immune cells. Thus, in this review, we describe the recent progression in cellular and humoral immunity studies during the progression of HPV-related cancers. First of all, we describe the role of B, plasmoid cells, and B regulatory cells (Breg) in their functions in the tumor microenvironment. Then, different subtypes of T cells such as T CD8, CD4, T regulatory (Treg) cells were studied in recently published papers. Furthermore, NK cells and their role in tumor progression and prevention were studied. Finally, we indicate the breakthroughs in immunotherapy techniques for HPV-related cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
184. Glyceraldehyde Phosphate at the Reducing Terminus of <em>Salmonella</em> O Haptens.
- Author
-
Gmeiner, Jobst
- Subjects
SALMONELLA typhimurium ,SALMONELLA ,POLYSACCHARIDES ,ANTIGENS ,PHOSPHATES ,ENZYMES - Abstract
The O antigen polysaccharide of Salmonella montevideo was isolated from a core-defective mutant by the phenol/water procedure, and was suspected to contain phosphomonoester and cyclic phosphodiester at its reducing end in anology to the O hapten from Salmonella typhimurium (Kent and Osborn, 1968). Therefore, it was chromatographed on a DEAE-cellulose column. Whereas one part eluted with water the other part of the polysaccharide could only be eluted with buffer. Both fractions were further purified on Sephadex G100 and contained mannose, glucose, N-acetylglucosamine and phosphate in a molar ratio of 4:1:1: < 0.1. In order to specifically label the reducing end phosphate was removed enzymatically, or the presumed cyclic diester was cleaved by mild hydrolysis, and the fractions were reduced with sodium boro[³H]hydride. Both fractions yield mainly [³H]glycerol after hydrolysis and paper chromatography. In addition, [³H]mannitol and [³H]monohydroxyacetone could be identified by paper chromatography and were concluded to be the result of phosphate migration and β-elimination reactions taking place during the isolation procedure and the various treatments prior to sodium boro[³H]-hydride reduction. These findings in addition to periodate oxidation studies indicated that the O antigen polysaccharide of Salmonella montevideo had glyceraldehyde phosphate at its reducing end. From the incorporation of ³H into the polysaccharide the O antigen was calculated to consist of about 19 repeating units of 6 sugar residues each. [ABSTRACT FROM AUTHOR]
- Published
- 1975
- Full Text
- View/download PDF
185. Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions.
- Author
-
Lokhov, Petr G., Lichtenberg, Steven, and Balashova, Elena E.
- Subjects
CANCER vaccines ,LANDSCAPE changes ,PROTEOMICS ,ANTIGENS ,MASS spectrometry - Abstract
The creation of cancer vaccines is a constant priority for research and biotechnology. Therefore, the emergence of any new technology in this field is a significant event, especially because previous technologies have not yielded results. Recently, the development of a cancer vaccine has been complemented by a new proteomics technology platform that allows the creation of antigen compositions known as antigenic essences. Antigenic essence comprises a target fraction of cellular antigens, the composition of which is precisely controlled by peptide mass spectrometry and compared to the proteomic footprint of the target cells to ensure similarity. This proteomics platform offers potential for a massive upgrade of conventional cellular cancer vaccines. Antigenic essences have the same mechanism of action, but without the disadvantages, and with notable advantages such as precise targeting of the immune response, safety, controlled composition, improved immunogenicity, addressed MHC restriction, and extended range of vaccination doses. The present paper calls attention to this novel platform, stimulates discussion of the role of antigenic essence in vaccine development, and consolidates academic science with biotech capabilities. A brief description of the platform, list of cellular cancer vaccines suitable for the upgrade, main recommendations, limitations, and legal and ethical aspects of vaccine upgrade are reported here. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
186. Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases.
- Author
-
Endres, Dominique, Maier, Viktoria, Leypoldt, Frank, Wandinger, Klaus-Peter, Lennox, Belinda, Pollak, Thomas A., Nickel, Kathrin, Maier, Simon, Feige, Bernd, Domschke, Katharina, Prüss, Harald, Bechter, Karl, Dersch, Rick, and Tebartz van Elst, Ludger
- Subjects
AUTOANTIBODIES ,NEUROLOGICAL disorders ,PSYCHOSES ,SYSTEMATIC reviews ,AUTOIMMUNE diseases ,SYMPTOMS ,DESCRIPTIVE statistics ,MEDLINE ,ANTIGENS - Abstract
Background: Autoimmune encephalitis (AE) is an important consideration during the diagnostic work-up of secondary mental disorders. Indeed, isolated psychiatric syndromes have been described in case reports of patients with underlying AE. Therefore, the authors performed a systematic literature review of published cases with AE that have predominant psychiatric/neurocognitive manifestations. The aim of this paper is to present the clinical characteristics of these patients. Methods: The authors conducted a systematic Medline search via Ovid, looking for case reports/series of AEs with antineuronal autoantibodies (Abs) against cell surface/intracellular antigens combined with predominant psychiatric/neurocognitive syndromes. The same was done for patients with Hashimoto encephalopathy/SREAT. Only patients with signs of immunological brain involvement or tumors in their diagnostic investigations or improvement under immunomodulatory drugs were included. Results: We identified 145 patients with AE mimicking predominant psychiatric/neurocognitive syndromes. Of these cases, 64% were female, and the mean age among all patients was 43.9 (±22.1) years. Most of the patients had Abs against neuronal cell surface antigens (55%), most frequently against the NMDA-receptor (N = 46). Amnestic/dementia-like (39%) and schizophreniform (34%) syndromes were the most frequently reported. Cerebrospinal fluid changes were found in 78%, electroencephalography abnormalities in 61%, and magnetic resonance imaging pathologies in 51% of the patients. Immunomodulatory treatment was performed in 87% of the cases, and 94% of the patients responded to treatment. Conclusions: Our findings indicate that AEs can mimic predominant psychiatric and neurocognitive disorders, such as schizophreniform psychoses or neurodegenerative dementia, and that affected patients can be treated successfully with immunomodulatory drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
187. Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine.
- Author
-
Sha, Huizi, Liu, Qin, Xie, Li, Shao, Jie, Yu, Lixia, Cen, Lanqi, Li, Lin, Liu, Fangcen, Qian, Hanqing, Wei, Jia, and Liu, Baorui
- Subjects
PHYLLODES tumors ,PEPTIDES ,TUMOR markers ,ANTIGENS ,FEBRILE neutropenia ,GRANULOCYTE-macrophage colony-stimulating factor ,HLA histocompatibility antigens ,METASTASIS - Abstract
Some of the mutant peptides produced by gene mutation transcription and translation have the ability to induce specific T cells, which are called new antigens. Neoantigen-based peptide, DNA, RNA, and dendritic cell vaccines have been used in the clinic. In this paper, we describe a lung metastasis of a phyllodes tumor patient demonstrating pathological complete response following treatment containing personalized multi-epitope peptide neoantigen nano-vaccine. Based on whole-exome sequencing (WES), RNA sequencing, and new antigen prediction, several mutated peptide fragments were predicted to bind to the patient's human leukocyte antigen (HLA) allotypes, including ten peptides with high predicted binding affinity for six genes. The pulmonary metastases remained stable after the four cycles of anti-PD1 and anlotinib. After the addition of the multi-epitope peptide neoantigen nano-vaccine, the tumor began to collapse and contracture developed, accompanied by a decrease of tumor markers to normal, and complete pathological remission was achieved. With the use of the vaccination, recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was used every time, and low-dose cyclophosphamide was injected every 3 weeks to improve efficacy. Peripheral blood immune monitoring demonstrated immune reactivity against a series of peptides, with the most robust post-vaccine T-cell response detected against the HLA-DRB1*0901-restricted SLC44A5 V54F peptide. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
188. SARS Cov-2 vaccines and vaccination strategies.
- Author
-
C. H., Nihala Naseefa and P., Sheeba
- Subjects
COVID-19 pandemic ,VACCINES ,ANTIGENS ,IMMUNOTHERAPY ,VACCINATION - Abstract
A rapid change has been undergone in the current pandemic and many countries are being exposed to the third wave of COVID-19. The tireless work for the discovery of vaccine had begun by the time the disease occupied a major part of the globe. This is mainly due to the efficacy of vaccines in preventing diseases and it is one of the cost effective strategies adopted for the prevention of many diseases. Currently a lot of countries have come forth with suitable vaccines to tackle the SARS CoV-2 to some extent. This paper incorporates details about vaccination and the common vaccines in use against COVID-19. Based on the evidences available, keen observations and studies carried out on the previously emerged SARS and MERS, the vaccine against SARS CoV-2 was developed, however the primary focus depend on the spike protein which was considered as a target for the development of suitable immunotherapies and thereby played a potential role in the vaccine development process. Vaccination is the most significant strategy to stop the pandemic and the efficacy of SARS-CoV-2 vaccines provides a genuine gauge of hope for future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
189. Atypical immunophenotype of chronic lymphocytic leukemia.
- Author
-
Urbaniak, Marta, Iskierka-Jazdzewska, Elzbieta, Majchrzak, Agata, and Robak, Tadeusz
- Subjects
CHRONIC lymphocytic leukemia ,ANTIGENS ,CD5 antigen ,CD19 antigen ,CD23 antigen - Abstract
Assessment of the immunophenotype plays a crucial role in the diagnostic process of chronic lymphocytic leukemia (CLL). The expression of CD5, CD19 and CD23 antigens with a concomitant reduction or lack of surface immunoglobulin expression as well as CD22 and CD79b antigens is the basic part of CLL diagnosis. A significant diagnostic challenge is atypical CLL with cells devoid of CD5 or CD23 antigens. The assessment of additional antigens in flow cytometry, especially the CD200 glycoprotein, may facilitate the process of differential diagnosis of atypical CLL from other B-cell lymphoproliferative neoplasms. The results of current studies analyzing the influence of atypical CLL on prognosis are inconclusive. The analysis of a large group of patients with atypical CLL is difficult because of the rare occurrence of CD5(–) or CD23(–) CLL and the misdiagnosis of this disease as other B-cell lymphoproliferative neoplasms. The following paper aims to show how important it is to include atypical CLL in the diagnostic process of this disease and to re-standardize the commonly used immunophenotypic scales for its diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
190. METODIKA KOLEKTIVNÍHO ANTIGENNÍHO SCREENINGU NA PŘÍTOMNOST VIRU SARS-COV-2.
- Author
-
Bryjová, Iveta, Stonišová, Radka, and Nedvědová, Daniela
- Subjects
COVID-19 ,POINT-of-care testing ,RESEARCH methodology ,MEDICAL screening ,QUALITATIVE research ,DESCRIPTIVE statistics ,SENSITIVITY & specificity (Statistics) ,GROUP process ,ANTIGENS ,ALGORITHMS - Abstract
Copyright of Nursing Perspectives / Ošetřovatelské Perspektivy is the property of Silesian University in Opava, Faculty of Public Policies in Opava and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
191. First person - Sara Hernández Pérez.
- Subjects
B cells ,CYTOSKELETON ,DOCTORAL students ,PERIODICAL publishing ,ANTIGENS - Abstract
First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping early-career researchers promote themselves alongside their papers. Sara Hernández Pérez is first author on 'B cells rapidly target antigen and surface-derived MHCII into peripheral degradative compartments', published in JCS. Sara is a PhD student in the lab of Pieta K. Mattila at University of Turku, Institute of Biomedicine, Finland, investigating the role of Rab proteins and the actin cytoskeleton in antigen trafficking and B cell activation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
192. Upregulation of CD22 by Chidamide promotes CAR T cells functionality.
- Author
-
Yang, Xin, Yu, Qiuxia, Xu, Hao, and Zhou, Jianfeng
- Subjects
HISTONES ,AUTOMOBILES ,TREATMENT failure ,T cells ,POST-translational modification ,DEACETYLASES ,CHIMERIC antigen receptors ,ANTIGENS - Abstract
Treatment failure or relapse due to tumor escape caused by reduction in target antigen expression has become a challenge in the field of CART therapy. Target antigen density is closely related to the effectiveness of CART therapy, and reduced or lost target antigen expression limits the efficacy of CART therapy and hinders the durability of CAR T cells. Epigenetic drugs can regulate histones for molecular modifications to regulate the transcriptional, translational and post-translational modification processes of target agents, and we demonstrated for the first time the role in regulating CD22 expression and its effect on the efficacy of CD22 CART. In this paper, we found that Chidamide promoted the expression of CD22 on the surface of B-cell tumor cells in vitro and in vivo, and enhanced the function of CD22 CART. As for mechanisms, we demonstrated that Chidamide did not affect CD22 mRNA transcription, but significantly increased the expression of total CD22 protein, indicating that Chidamide may upregulate cell surface CD22 expression by affecting the distribution of CD22 protein. In summary, our results suggest that Chidamide may enhance the efficacy of CD22 CART by inhibiting histone deacetylases to regulate post-transcriptional modifications that affect protein distribution to increase the expression of CD22 on the cell surface. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
193. Insights From Single Cell RNA Sequencing Into the Immunology of Type 1 Diabetes- Cell Phenotypes and Antigen Specificity.
- Author
-
Hanna, Stephanie J., Tatovic, Danijela, Thayer, Terri C., and Dayan, Colin M.
- Subjects
RNA sequencing ,TYPE 1 diabetes ,IMMUNOLOGY ,ANTIGENS ,PHENOTYPES - Abstract
In the past few years, huge advances have been made in techniques to analyse cells at an individual level using RNA sequencing, and many of these have precipitated exciting discoveries in the immunology of type 1 diabetes (T1D). This review will cover the first papers to use scRNAseq to characterise human lymphocyte phenotypes in T1D in the peripheral blood, pancreatic lymph nodes and islets. These have revealed specific genes such as IL-32 that are differentially expressed in islet –specific T cells in T1D. scRNAseq has also revealed wider gene expression patterns that are involved in T1D and can predict its development even predating autoantibody production. Single cell sequencing of TCRs has revealed V genes and CDR3 motifs that are commonly used to target islet autoantigens, although truly public TCRs remain elusive. Little is known about BCR repertoires in T1D, but scRNAseq approaches have revealed that insulin binding BCRs commonly use specific J genes, share motifs between donors and frequently demonstrate poly-reactivity. This review will also summarise new developments in scRNAseq technology, the insights they have given into other diseases and how they could be leveraged to advance research in the type 1 diabetes field to identify novel biomarkers and targets for immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
194. Amniotic Fluid Embolism Pathophysiology Suggests the New Diagnostic Armamentarium: β-Tryptase and Complement Fractions C3-C4 Are the Indispensable Working Tools.
- Author
-
Busardò, Francesco Paolo, Frati, Paola, Zaami, Simona, and Fineschi, Vittorio
- Subjects
AMNIOTIC fluid embolism ,TRYPTASE ,PREGNANCY complications ,DISEASE incidence ,IMMUNE response ,ANTIGENS - Abstract
Amniotic fluid embolism (AFE) is an uncommon obstetric condition involving pregnant women during labor or in the initial stages after delivery. Its incidence is estimated to be around 5.5 cases per 100,000 deliveries. Therefore, this paper investigated the pathophysiological mechanism, which underlies AFE, in order to evaluate the role of immune response in the development of this still enigmatic clinical entity. The following databases (from 1956 to September 2014) Medline, Cochrane Central, Scopus, Web of Science and Science Direct were used, searching the following key words: AFE, pathophysiology, immune/inflammatory response, complement and anaphylaxis. The main key word "AFE" was searched singularly and associated individually to each of the other keywords. Of the 146 sources found, only 19 were considered appropriate for the purpose of this paper. The clinical course is characterized by a rapid onset of symptoms, which include: acute hypotension and/or cardiac arrest, acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest), coagulopathies (disseminated intravascular coagulation and/or severe hemorrhage), coma and seizures. The pathology still determines a significant morbidity and mortality and potential permanent neurological sequelae for surviving patients. At this moment, numerous aspects involving the pathophysiology and clinical development are still not understood and several hypotheses have been formulated, in particular the possible role of anaphylaxis and complement. Moreover, the detection of serum tryptase and complement components and the evaluation of fetal antigens can explain several aspects of immune response. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
195. EXPRESSION OF CD68 ANTIGEN IN CHRONICALLY DISEASED HUMAN PALATINE TONSIL.
- Author
-
Kundalić, Braca, Stojanović, Vesna, Pavlović, Miljana, Živković, Vladimir, Trandafilović, Milena, Kokoris, Jovana Čukuranović, Antić, Milorad, and Graovac, Ivana
- Subjects
TONSILS ,LYMPHOID tissue ,GERMINAL centers ,DENDRITIC cells ,ANTIGENS - Abstract
Copyright of Acta Medica Medianae is the property of Acta Medica Medianae and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
196. Identification of linear epitopes on the flagellar proteins of Clostridioides difficile.
- Author
-
Razim, A., Pacyga, K., Naporowski, P., Martynowski, D., Szuba, A., Gamian, A., and Górska, S.
- Subjects
EPITOPES ,CLOSTRIDIOIDES difficile ,ALIMENTARY canal ,ANTIGENS ,POLYPEPTIDES - Abstract
Clostridioides difficile (C. difficile) is an opportunistic anaerobic bacterium that causes severe diseases of the digestive tract of humans and animals. One of the possible methods of preventing C. difficile infection is to develop a vaccine. The most promising candidates for vaccine antigens are the proteins involved in the adhesion phenomena. Among them, the FliC and FliD are considered to be suitable candidates. In this paper, the FliC and FliD protein polypeptide epitopes were mapped in silico and by using PEPSCAN procedure. We identified four promising epitopes:
117 QRMRTLS123 ,205 MSKAG209 of FliC and226 NKVAS230 ,306 TTKKPKD312 of FliD protein. We showed that117 QRMRTLS123 sequence is not only located in TLR5-binding and activating region, as previously shown, but forms an epitope recognized by C. difficile-infected patients' antibodies.205 MSKAG209 is a C. difficile-unique, immunogenic sequence that forms an exposed epitope on the polymerized flagella structure which makes it a suitable vaccine antigen.226 NKVAS230 and306 TTKKPKD312 are well exposed and possess potential protective properties according to VaxiJen analysis. Our results open the possibility to use these epitopes as suitable anti-C. difficile vaccine antigens. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
197. Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers.
- Author
-
Wimalasiri, V. W., Dunuweera, S. P., Dunuweera, A. N., and Rajapakse, R. M. G.
- Subjects
PROTEINS ,STRUCTURAL equation modeling ,DRUG delivery systems ,HYDROGEN-ion concentration ,MATHEMATICAL models ,DYNAMICS ,HAIR ,THEORY ,PACLITAXEL ,FOLIC acid ,CELL lines ,ANTIGENS ,KERATINOCYTES - Abstract
This paper describes a convenient and straightforward method developed to extract keratin particles (KPs) from human hair. It also involves their characterization by several methods and encapsulation of the anticancer drug Paclitaxel (Taxol) within them, aiming for targeted delivery to cancerous sites and slow release at their vicinity. The KPs obtained were in micrometer in size. They are capable of encapsulating Taxol within them with a high encapsulation efficiency of 56% and a drug loading capacity of 2.360 g of Taxol per g keratin. As revealed by the SEM elemental analysis, KPs do not contain any toxic metal ion, and hence, they pose no toxicity to human cells. The pH-dependent release kinetics of the drug from KPs indicates that the drug is released faster when the pH of the solution is increased in the 5.0 to 7.0 pH range. The release kinetics obtained is impressive, and once targeted to the cancerous sites, using cancer directing agents, such as folic acid; a glutamate urea ligand known as DUPA; aminopeptidase N, also known as CD13; and FAP-α-targeting agents, the slow release of the drug is expected to destroy only the cancerous cells. The Noyes-Whitney dissolution model was used to analyze the release behavior of Taxol from KPs, which shows excellent fitting with experimental data. The pH dependence of drug release from keratin is also explained using the 3-D structures and keratin stability at different pH values. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
198. The amino acid sequence of a δ light chain presenting abnormal physicochemical and antigenic features.
- Author
-
Mihaesco, Edith, Roy, Jean-Pierre, Congy, Nicole, Peran-Rivat, Liliane, and Mihaesco, Constantin
- Subjects
AMINO acid sequence ,PROTEIN analysis ,IMMUNOGLOBULIN A ,ANTIGENS ,MONOCLONAL antibodies ,IMMUNITY - Abstract
The amino acid sequence of the light chain of a human monoclonal IgA
1 (Mem) was established, in part by analogy with already known sequences. By homology its variable part was shown to belong to the VλI subgroup while the isotype-associated amino acid residues characterized it as Mcg+ , Kern+ and Oz- . The normal primary structure of this chain was in contrast to its abnormal physical and antigenic properties: (a) its apparent molecular mass estimated by SDS/polyacrylamide gel electrophoresis, by gel filtration chromatography and by gradient ultracentrifugation was found to be lower by &assymp; 10% than the values (23.5 kDa) of ‘normal’ light chain used as controls; (b) the λI chain Mem, when tested in native state was not antigenically reactive. These abnormalities were reverted when the chain was treated with 8 M urea. These data suggest that the abnormal behaviour of λI chain Mere is at a conformational level. [ABSTRACT FROM AUTHOR]- Published
- 1985
- Full Text
- View/download PDF
199. Immune responses in newly developed short-lived SAM mice II. SELECTIVELY IMPAIRED T-HELPER CELL ACTIVITY IN <em>IN VITRO</em> ANTIBODY RESPONSE.
- Author
-
Hosokawa, T., Hosono, M., Hanada, K., Aoike, A., Kawai, K., and Takeda, T.
- Subjects
T cells ,LEUCOCYTES ,IMMUNOGLOBULINS ,ANTIGENS ,LYMPHOCYTES ,CELL culture - Abstract
New short-lived strains of mice (SAM-P), which have been developed by Takeda et al. (1981), show a defective antibody response to T dependent (TD) antigen in vitro, as demonstrated in the accompanying paper (see page 419). In the present study, we investigated the cellular site of the defect, using a cell culture system. In this paper, it is demonstrated that T-helper (Th) cell activity for the antibody response to TD antigen is impaired, while other cellular immune responses, e.g. mixed leucocyte reaction, cytotoxic T-lymphocyte response, and delayed-type hypersensitivity reaction, are normal. These results suggest that the defect in T-helper subset is limited in helper function for the antibody response, and that the helper function for the cell-mediated immune responses is intact. These two functions of the T-helper subset are apparently regulated in a different manner. The SAM-P strains of mice may thus serve as an appropriate model for studying functional heterogeneity in T-helper/inducer cell subsets. [ABSTRACT FROM AUTHOR]
- Published
- 1987
200. Immunochemical Studies on <em>Citrobacter</em> O Antigens (Lipopolysaccharides).
- Author
-
Keleti, Juraj, Lüderitz, Otto, Mlynarčík, Dušan, and Sedlák, Jiři
- Subjects
ENDOTOXINS ,MICROBIAL polysaccharides ,BACTERIAL antigens ,ANTIGENS ,SALMONELLA ,IMMUNOCHEMISTRY - Abstract
An investigation on the sugar compositions of lipopolysaccharides (O antigens) derived from 45 well—defined Citrobacter serotypes was carried out. As a result, a chemical classification into 20 chemotypes was achieved, of which 11 were identical with chemotypes occurring in Salmonella and Escherichia coli. All Citrobacter lipopolysaccharides contained glucosamine, glucose, heptose, 2-keto-3-deoxyoctonate and galactose, the latter, in some cases, in very small amounts. These sugars probably represent building blocks of the basal core polysaccharides, whose structures however may not be identical for all Citrobacter lipopolysaccharides. In addition to the basal sugars, the following monosaccharides were detected as constituents of the various Citrobacter lipopolysaccharides; D-xylose, D-mannose, fucose, rhamnose, 6-deoxylatose, 4-deoxy-D-idose, abequose, galactosamine, D-fucosamine, 3-amino-3,6-dideoxy-glucose and -galactose. The sugar compositions of serologically related Citrobacter and Salmonella O antigens were compared. While some cross-reacting pairs belonged to the same chemotype, other proved to be distinct with respect to their sugar constituents. [ABSTRACT FROM AUTHOR]
- Published
- 1971
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.